InMed Pharmaceuticals Inc. (NASDAQ:INM) Expected to Post Earnings of -$0.23 Per Share

Equities analysts expect InMed Pharmaceuticals Inc. (NASDAQ:INM – Get Rating) to announce ($0.23) earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have made estimates for InMed Pharmaceuticals’ earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.21). InMed Pharmaceuticals posted earnings per share of ($0.41) in the same […]

Related Keywords

,Exchange Commission ,Morgan Stanley ,Inmed Pharmaceuticals ,Inmed Pharmaceuticals Company Profile Get Rating ,Zacks Investment Research ,Inmed Pharmaceuticals Inc ,Nasdaq ,Get Rating ,Inmed Pharmaceutical ,Med Pharmaceuticals ,Investment Research ,Roth Capital ,Med Pharmaceuticals Company Profile ,Med Pharmaceuticals Inc ,Nasdaq Inm ,Pinm ,Medical ,Ratings ,Consensus ,